GAMCO Investors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
GAMCO Investors's DICE Position: Q3 2023 in Review
GAMCO Investors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 61,100 shares — an estimated $2.84M sold.
GAMCO Investors first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $2.84M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.
- GAMCO Investors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- GAMCO Investors sold 61,100 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.84M.
- GAMCO Investors first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
- GAMCO Investors's DICE Therapeutics, Inc. Common Stock position peaked at $2.84M in Q2 2023.
- 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.
Based on GAMCO Investors's 13F filing for Q3 2023, filed 8 Nov 2023.